The HPTN 083 study team and the Community Relation Coordinator visited the Caremat Health Center and Mplus foundation on October 8, 2020 and October 22, 2020 respectively.

The final results of HPTN 083 study on the long acting antiretroviral injection cabotegravir as a new HIV prevention strategy have been discussed with these community-based organizations who have been actively working on HIV prevention for the specific population; MSMs/TGs and adolescents.

Caremat.jpg
Caremat2.jpg
Mplus2.jpg
Mplus.jpg
1603527480887.jpg

©2019 by Research Center for Infectious Diseases and Substance Use. Proudly created with Wix.com